Stroma-epithelium crosstalk in prostate cancer.
暂无分享,去创建一个
S. Xia | Y. Niu | Shu-Jie Xia | Yi-Nong Niu
[1] M. Ittmann,et al. The role of fibroblast growth factors and their receptors in prostate cancer. , 2004, Endocrine-related cancer.
[2] D. Tindall,et al. TGF-betal/Smad signaling in prostate cancer. , 2003, Current drug targets.
[3] H. Jin,et al. Integrins: roles in cancer development and as treatment targets , 2004, British Journal of Cancer.
[4] M. Gerdes,et al. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF‐β1 , 2004, The Prostate.
[5] P. Nelson,et al. Interaction of IGF signaling and the androgen receptor in prostate cancer progression , 2006, Journal of cellular biochemistry.
[6] Hui Wang,et al. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II. , 2008, Cancer research.
[7] P. Scherle,et al. Targeting the c-MET signaling pathway for cancer therapy , 2008 .
[8] R. Sutherland,et al. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. , 2001, Cancer research.
[9] L. Eaves,et al. cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells , 2005, Molecular carcinogenesis.
[10] D. Horsfall,et al. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non‐organ confined disease , 2005, The Prostate.
[11] Anna Johansson,et al. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model , 2007, The Prostate.
[12] R. Vessella,et al. The role of tumor microenvironment in prostate cancer bone metastasis , 2007, Journal of cellular biochemistry.
[13] R. Roberts,et al. The loss of TGF-beta signaling promotes prostate cancer metastasis. , 2003, Neoplasia.
[14] L. Chung,et al. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. , 2005, The Journal of urology.
[15] K. Jennbacken,et al. Expression of vascular endothelial growth factor C (VEGF‐C) and VEGF receptor‐3 in human prostate cancer is associated with regional lymph node metastasis , 2005, The Prostate.
[16] Yuzhuo Wang,et al. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression. , 2007, Cancer research.
[17] R. West,et al. Experimental approaches to the study of cancer–stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis , 2007, Laboratory Investigation.
[18] D. Tindall,et al. TGF-ß/Smad Signaling in Prostate Cancer , 2003 .
[19] P. Limonta,et al. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I. , 2007, International journal of oncology.
[20] T. Kole,et al. Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. , 2008, Biochemistry.
[21] R. Dhir,et al. Microenvironment of Prostate Cancer Receptor-Coregulator Recruitment Is Altered in the Tissue Stromal-Epithelial Cell Interactions and Androgen , 2007 .
[22] K. Williams,et al. Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. , 2006, Cancer research.
[23] H. Moses,et al. Stromal fibroblasts in cancer initiation and progression , 2004, Nature.
[24] S. Batra,et al. Prostate‐derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor‐positive human prostate cancer cells , 2007, The Prostate.
[25] G. Ayala,et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[27] D. Danielpour. Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. , 2005, European journal of cancer.
[28] J. S. Rao,et al. CpG island promoter methylation and silencing of 14-3-3σ gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2 , 2006, Oncogene.
[29] W. Mckeehan,et al. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy , 1993, Molecular and cellular biology.
[30] P. Hein,et al. Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.
[31] M. T. Story,et al. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells , 1996, The Prostate.
[32] J. Gillespie,et al. Gene promoter methylation in prostate tumor-associated stromal cells. , 2006, Journal of the National Cancer Institute.
[33] Jianhua Wang,et al. Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. , 2005, Cellular signalling.
[34] M. S. Condon. The role of the stromal microenvironment in prostate cancer. , 2005, Seminars in cancer biology.
[35] T. Kipps,et al. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.
[36] S. Hayward,et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.
[37] Yi Lu,et al. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. , 2006, Cancer research.
[38] Brian Bierie,et al. Under Pressure: Stromal Fibroblasts Change Their Ways , 2005, Cell.
[39] Yulan Jin,et al. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate. , 2003, Oncology reports.
[40] A. Gudkov,et al. Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells , 2004 .
[41] P. Greenberg,et al. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. , 1998, Endocrinology.
[42] Zhiwei Wang,et al. Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells , 2008, Stem cells.
[43] Georg Bartsch,et al. Interleukin‐6 regulation of prostate cancer cell growth , 2005, Journal of cellular biochemistry.
[44] A. Angelucci,et al. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity , 2005, Thrombosis and Haemostasis.
[45] Liang Cheng,et al. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model. , 2004, Anticancer research.
[46] A. Multani,et al. Can cancer cells transform normal host cells into malignant cells? , 1997, British Journal of Cancer.
[47] K. Pienta,et al. Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells , 2005 .
[48] P. Febbo,et al. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells. , 2007, The American journal of pathology.
[49] L. Ye,et al. HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells. , 2008, Urologic oncology.
[50] L. Chung,et al. Co‐inoculation of tumorigenic rat prostate mesenchymal cells with non‐tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals , 1989, International journal of cancer.
[51] J. Gillespie,et al. Identification of a unique epigenetic sub‐microenvironment in prostate cancer , 2007, The Journal of pathology.
[52] N. Maitland,et al. Androgen receptor signalling in prostate: Effects of stromal factors on normal and cancer stem cells , 2008, Molecular and Cellular Endocrinology.
[53] E. Baldi,et al. EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen‐sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR) , 2004, International journal of cancer.
[54] R. Cowan,et al. Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. , 2007, International journal of radiation oncology, biology, physics.
[55] P. Stattin,et al. Castration‐induced epithelial cell death in human prostate tissue is related to locally reduced IGF‐1 levels , 2007, The Prostate.
[56] P. Stattin,et al. Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non‐malignant human prostate tissue several months after castration therapy , 2007, The Prostate.
[57] Wenjun Guo,et al. Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.
[58] N. Maitland,et al. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. , 1998, Cancer research.
[59] Donald E Ingber,et al. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. , 2002, Differentiation; research in biological diversity.
[60] L. Chung,et al. Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells , 2006, Clinical & Experimental Metastasis.
[61] Abraham Schneider,et al. Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[62] J. Arnold,et al. Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[63] Kirsten L. Greene,et al. CpG methylation at promoter site −140 inactivates TGFβ2 receptor gene in prostate cancer , 2005, Cancer.
[64] C. Heldin,et al. New members of the platelet-derived growth factor family of mitogens. , 2002, Archives of biochemistry and biophysics.
[65] J. Schalken,et al. Complex cadherin expression in human prostate cancer cells , 2000, International journal of cancer.
[66] Kathleen A. Hinchman,et al. Progression , 1896, Journal of Adolescent & Adult Literacy.
[67] Feng Yang,et al. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. , 2005, Cancer research.
[68] Kornelia Polyak,et al. Microenvironmental regulation of cancer development. , 2008, Current opinion in genetics & development.
[69] 前田 明信. Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells , 2007 .
[70] S. Persad,et al. Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells , 2008, Cancer Cell International.
[71] G. Ghersi. Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis. , 2008, Frontiers in bioscience : a journal and virtual library.
[72] C. Pettaway,et al. Blockade of Transforming Growth Factor-β Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude Mice , 2005, Clinical Cancer Research.
[73] K. Williams,et al. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. , 2007, Cancer research.
[74] M. Washington,et al. TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.
[75] J. Grootegoed,et al. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling. , 2005, Endocrine-related cancer.
[76] B. Knudsen,et al. Prostate cancer and the met hepatocyte growth factor receptor. , 2004, Advances in cancer research.
[77] J. Schalken,et al. Cadherin switching in human prostate cancer progression. , 2000, Cancer research.
[78] A. Gao,et al. Interleukin‐6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression , 2007, The Prostate.
[79] H. Moses,et al. Tumor-stroma interactions. , 2005, Current opinion in genetics & development.
[80] L. Chung,et al. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells , 2006, BMC Cancer.
[81] Robert D. Cardiff,et al. Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.
[82] T. Ratliff. TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .
[83] Olivier De Wever,et al. Role of tissue stroma in cancer cell invasion , 2003, The Journal of pathology.